|
|
|
R E S O L U T I O N
|
|
BE IT RESOLVED by the House of Representatives of the State of |
|
Texas, 86th Legislature, Regular Session, 2019, That House Rule 13, |
|
Section 9(a), be suspended in part as provided by House Rule 13, |
|
Section 9(f), to enable the conference committee appointed to |
|
resolve the differences on House Bill 3284 (the prescribing and |
|
dispensing of controlled substances under the Texas Controlled |
|
Substances Act; authorizing a fee; providing for administrative |
|
penalties; creating criminal offenses) to consider and take action |
|
on the following matters: |
|
(1) House Rule 13, Section 9(a)(2), is suspended to permit |
|
the committee to omit text not in disagreement by omitting SECTION 1 |
|
of the house engrossment of House Bill 3284 and the corresponding |
|
SECTION of the bill as the bill was amended by the senate adding |
|
Section 481.0755, Health and Safety Code, which reads as follows: |
|
SECTION 1. Subchapter C, Chapter 481, Health and Safety |
|
Code, is amended by adding Section 481.0755 to read as follows: |
|
Sec. 481.0755. WRITTEN, ORAL, AND TELEPHONICALLY |
|
COMMUNICATED PRESCRIPTIONS. (a) Notwithstanding Sections |
|
481.073, 481.074, and 481.075, a person prescribing or dispensing a |
|
controlled substance must use the electronic prescription record |
|
and may not use a written, oral, or telephonically communicated |
|
prescription. |
|
(b) A prescriber may issue a written, oral, or |
|
telephonically communicated prescription for a controlled |
|
substance as authorized under this subchapter only if the |
|
prescription is issued: |
|
(1) by a veterinarian; |
|
(2) in circumstances in which electronic prescribing |
|
is not available due to temporary technological or electronic |
|
failure, as prescribed by board rule; |
|
(3) by a practitioner to be dispensed by a pharmacy |
|
located outside this state, as prescribed by board rule; |
|
(4) when the prescriber and dispenser are the same |
|
entity; |
|
(5) in circumstances in which necessary elements are |
|
not supported by the most recent electronic prescription drug |
|
software; |
|
(6) for a drug for which the United States Food and |
|
Drug Administration requires additional information in the |
|
prescription that is not possible with electronic prescribing; |
|
(7) for a non-patient-specific prescription pursuant |
|
to a standing order, approved protocol for drug therapy, |
|
collaborative drug management, or comprehensive medication |
|
management, in response to a public health emergency or in other |
|
circumstances in which the practitioner may issue a |
|
non-patient-specific prescription; |
|
(8) for a drug under a research protocol; |
|
(9) by a prescriber who is employed by or is practicing |
|
a health care profession at a health-related institution, as |
|
defined by Section 62.161, Education Code, as added by Chapter 448 |
|
(H.B. 7), Acts of the 84th Legislature, 2015; |
|
(10) by a practitioner who has received a waiver under |
|
Subsection (c) from the requirement to use electronic prescribing; |
|
or |
|
(11) under circumstances in which the practitioner has |
|
the present ability to submit an electronic prescription but |
|
reasonably determines that it would be impractical for the patient |
|
to obtain the drugs prescribed under the electronic prescription in |
|
a timely manner and that a delay would adversely impact the |
|
patient's medical condition. |
|
(c) The board shall adopt rules establishing a process by |
|
which a practitioner may request and receive a waiver under |
|
Subsection (b)(10), not to exceed one year, from the requirement to |
|
use electronic prescribing. The board shall adopt rules |
|
establishing the eligibility for a waiver, including: |
|
(1) economic hardship; |
|
(2) technological limitations not reasonably within |
|
the control of the practitioner; or |
|
(3) other exceptional circumstances demonstrated by |
|
the practitioner. |
|
(d) A written, oral, or telephonically communicated |
|
prescription must comply with the applicable requirements |
|
prescribed by Sections 481.074 and 481.075. |
|
(e) A dispensing pharmacist who receives a controlled |
|
substance prescription in a manner other than electronically is not |
|
required to verify that the prescription is exempt from the |
|
requirement that it be submitted electronically. |
|
(f) The board shall enforce this section. |
|
Explanation: This change is necessary to avoid conflicting |
|
with language in House Bill 2174 that also adds Section 481.0755, |
|
Health and Safety Code. The house has concurred in the senate |
|
amendments to House Bill 2174. |
|
(2) House Rule 13, Sections 9(a)(1) and (2), are suspended |
|
to permit the committee to change and omit text not in disagreement |
|
in SECTIONS 6 and 9 of the house engrossment of House Bill 3284 and |
|
the corresponding SECTIONS of the bill as the bill was amended by |
|
the senate to strike references to Section 481.0755, Health and |
|
Safety Code. |
|
Explanation: This change is necessary to conform |
|
cross-references to the omission of proposed Section 481.0755, |
|
Health and Safety Code. |
|
(3) House Rule 13, Section 9(a)(2), is suspended to permit |
|
the committee to omit text not in disagreement by omitting SECTION |
|
13 of the house engrossment of House Bill 3284 and the corresponding |
|
SECTION of the bill as the bill was amended by the senate, which |
|
reads as follows: |
|
SECTION 13. Section 481.0755, Health and Safety Code, as |
|
added by this Act, applies only to a prescription issued on or after |
|
the effective date of this Act. |
|
Explanation: This change is necessary to conform to the |
|
omission of proposed Section 481.0755, Health and Safety Code. |
|
|
Sheffield |
|
|
|
______________________________ |
|
Speaker of the House |
|
|
I certify that H.R. No. 2195 was adopted by the House on May |
|
26, 2019, by the following vote: Yeas 139, Nays 4, 1 present, not |
|
voting. |
|
|
|
______________________________ |
|
Chief Clerk of the House |
|